TY - JOUR
T1 - Gender disparities in clinical presentation, treatment, and outcomes in metastatic spine disease
AU - Price, Meghan
AU - Goodwin, Jessica C.
AU - De la Garza Ramos, Rafael
AU - Baëta, César
AU - Dalton, Tara
AU - McCray, Edwin
AU - Yassari, Reza
AU - Karikari, Isaac
AU - Abd-El-Barr, Muhammad
AU - Goodwin, Andrea N.
AU - Rory Goodwin, C.
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2021/2
Y1 - 2021/2
N2 - Background: The incidence of metastatic spine disease (MSD) is increasing among cancer patients. Given the poor outcomes and high rates of morbidity associated with MSD, it is important to determine demographic factors that could impact interventions and outcomes for this patient population. The objectives of this study were to compare in-hospital mortality and complication rates, clinical presentation, and interventions between female and male patients diagnosed with MSD. Methods: Patient data were collected from the United States National Inpatient Sample (NIS) database from the years 2012−2014. Descriptive statistics were used to compare data from 51,800 cases; subsequently, multivariable logistic regression analyses were conducted to assess the effect of gender on outcomes. Results: Males had significantly higher rates of in-hospital mortality (OR 1.30; 95 % CI 1.09–1.56, p = 0.004) and were more likely to have received surgical intervention than females (OR 1.34; 95 % CI 1.16–1.55, p < 0.001). Additionally, female patients were more likely to present with vertebral compression fracture (p < 0.001), while metastatic spinal cord compression (MSCC) and paralysis were more common in male patients (p < 0.001). There was no significant difference in rates of in-hospital complications between female and male patients. Conclusion: Given the significant differences in mortality, disease course, treatment, and in-hospital complications between female and male patients diagnosed with MSD, additional prospective studies are necessary to understand how to meaningfully incorporate these differences into clinical care and prognostication going forward.
AB - Background: The incidence of metastatic spine disease (MSD) is increasing among cancer patients. Given the poor outcomes and high rates of morbidity associated with MSD, it is important to determine demographic factors that could impact interventions and outcomes for this patient population. The objectives of this study were to compare in-hospital mortality and complication rates, clinical presentation, and interventions between female and male patients diagnosed with MSD. Methods: Patient data were collected from the United States National Inpatient Sample (NIS) database from the years 2012−2014. Descriptive statistics were used to compare data from 51,800 cases; subsequently, multivariable logistic regression analyses were conducted to assess the effect of gender on outcomes. Results: Males had significantly higher rates of in-hospital mortality (OR 1.30; 95 % CI 1.09–1.56, p = 0.004) and were more likely to have received surgical intervention than females (OR 1.34; 95 % CI 1.16–1.55, p < 0.001). Additionally, female patients were more likely to present with vertebral compression fracture (p < 0.001), while metastatic spinal cord compression (MSCC) and paralysis were more common in male patients (p < 0.001). There was no significant difference in rates of in-hospital complications between female and male patients. Conclusion: Given the significant differences in mortality, disease course, treatment, and in-hospital complications between female and male patients diagnosed with MSD, additional prospective studies are necessary to understand how to meaningfully incorporate these differences into clinical care and prognostication going forward.
KW - Gender disparity
KW - In-hospital complications
KW - Metastatic spine disease
KW - Mortality rates
KW - Presentation
UR - http://www.scopus.com/inward/record.url?scp=85097792107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097792107&partnerID=8YFLogxK
U2 - 10.1016/j.canep.2020.101856
DO - 10.1016/j.canep.2020.101856
M3 - Article
C2 - 33348243
AN - SCOPUS:85097792107
SN - 1877-7821
VL - 70
JO - Cancer Epidemiology
JF - Cancer Epidemiology
M1 - 101856
ER -